Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 7—July 2012


Validity of International Health Regulations in Reporting Emerging Infectious Diseases

Michael EdelsteinComments to Author , David L. Heymann, Johan Giesecke, and Julius Weinberg

Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (M. Edelstein, D.L. Heymann); Chatham House, London (D.L. Heymann); European Centre for Disease Control, Stockholm, Sweden (J. Giesecke); and Kingston University, London (J. Weinberg)

Main Article

Table 3

Characteristics of 46 EID events of international public health concern reported to WHO*

Characteristic No. (%)
Type of pathogen
Bacterium 21 (45.6)
Virus 18 (39.1)
Rickettsia 2 (4.3)
Protozoan 3 (6.5)
Other† 2 (4.3)
WHO region
AMRO 17 (37.0)
EURO 12 (26.1)
EMRO 3 (6.5)
SEARO 2 (4.3)
WPRO 7(15.2)
AFRO 5 (10.9)
Type of event
New pathogen 19 (41.3)
Increased incidence 18 (39.1)
Antimicrobial drug resistance 8 (17.4)
New clinical manifestation 1 (2.2)

*EID, emerging infectious disease; WHO, World Health Organization; AMRO, Americas; EURO, Europe; EMRO, Eastern Mediterranean; SEARO, Southeast Asia; WPRO, Western Pacific; AFRO, Africa.
†Helminth, prion, or fungus.

Main Article